Page last updated: 2024-08-24

triazoles and mefloquine

triazoles has been researched along with mefloquine in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Coulaud, JP; Ngo Van, P1
Benwell, K; Cliffe, IA; Dourish, CT; Gillespie, RJ; Knight, AR; Lerpiniere, J; Misra, A; Pratt, RM; Revell, D; Upton, R; Weiss, SM1
Blackie, MA; de Kock, C; Hamann, AR; Smith, PJ; van Otterlo, WA1
Fisher, E; García-Sastre, A; He, S; Kouznetsova, J; Long, Y; Martínez-Romero, C; Motabar, O; Qiu, X; Sanderson, PE; Shinn, P; Sun, W; Tawa, G; Williamson, PR; Xu, M; Yang, S; Zheng, W1

Other Studies

4 other study(ies) available for triazoles and mefloquine

ArticleYear
[New antiparasitic drugs].
    Annales de dermatologie et de venereologie, 1988, Volume: 115, Issue:4

    Topics: Amebicides; Anthelmintics; Antifungal Agents; Antimalarials; Artemisinins; Fluconazole; Humans; Itraconazole; Ketoconazole; Mefloquine; Phenanthrenes; Quinolines; Sesquiterpenes; Triazoles

1988
Discovery of nonxanthine adenosine A2A receptor antagonists for the treatment of Parkinson's disease.
    Neurology, 2003, Dec-09, Volume: 61, Issue:11 Suppl 6

    Topics: Adenosine; Adenosine A2 Receptor Antagonists; Animals; Antiparkinson Agents; Binding, Competitive; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Design; Drug Evaluation, Preclinical; Humans; Ligands; Mefloquine; Mice; Motor Activity; Neuroprotective Agents; Parkinsonian Disorders; Phenethylamines; Purines; Pyrimidines; Radioligand Assay; Rats; Triazines; Triazoles

2003
Synthesis of novel triazole-linked mefloquine derivatives: biological evaluation against Plasmodium falciparum.
    Bioorganic & medicinal chemistry letters, 2014, Dec-01, Volume: 24, Issue:23

    Topics: Antimalarials; Humans; Malaria; Mefloquine; Molecular Structure; Plasmodium falciparum; Structure-Activity Relationship; Triazoles

2014
Synergistic drug combination effectively blocks Ebola virus infection.
    Antiviral research, 2017, Volume: 137

    Topics: Animals; Antiviral Agents; Cell Line; Chlorocebus aethiops; Clarithromycin; Drug Combinations; Drug Synergism; Ebolavirus; Hemorrhagic Fever, Ebola; High-Throughput Screening Assays; Humans; Mefloquine; Sphingomyelin Phosphodiesterase; Toremifene; Triazoles; Vero Cells; Virus Internalization

2017